Analysis of the clinical use of antiviral treatment in patients taking into account the morphological mechanisms of growth of glial tumors contaminated with herpes simplex virus
https://doi.org/10.56618/2071-2693_2024_16_2_42
EDN: MPPSJE
Abstract
INTRODUCTION. The general strategy for the growth of neuroepithelial tumors is a cascade of changes in the biological behavior of tumor cells and vascular endothelium that occur during the progression of the tumor process, taking into account transformation.
MATERIALS AND METHODS. The study material included current and archival biopsies of 780 highly malignant glial tumors contaminated with herpes simplex virus (HSV).
To detect HSV in tumors, an immunohistochemical (IHC) study was performed with antibodies to the HSV antigen. The control groups consisted of tumors that did not express antibodies to HSV and in which intranuclear inclusions characteristic of HSV were not detected.
RESULTS. High-grade glial tumors, which include glioblastoma, anaplastic astrocytoma, anaplastic oligodendroglioma, anaplastic oligoastrocytoma, and anaplastic ependymoma, showed staged growth. The growth rate was determined by the ratio of growth factors, which include primarily the ratio of apoptotic p53 and anti-apoptotic factor bcl-2, the index of proliferative activity, as well as the number of vessels in the most vascularized (“hot”) spot. Part of the viral genome that entered the tumor and endothelial cells changed the growth rate of the host cell population. The productive inflammation that occurs in response to changes in the host cell genome stimulates proliferation processes, changing the rate of apoptosis. During the study, a method of using etiopathogenetic antiviral treatment was proposed.
CONCLUSION. The significance of the HSV genome for glial tumors is enormous. It tries to preserve the tumor cell, on the one hand, but sharply increases the ability of the endothelium to divide during the joint replication of genetic material, on the other hand. The result of the proven complex mechanism of growth of glial tumors was the method of etiopathogenic antiviral treatment, which made it possible to extend the relapse-free period by an average of two times for all groups of high-grade gliomas.
About the Authors
T. V. ZhukovaBelarus
Tatyana V. Zhukova – Dr. of Sci. (Med.), Associate Professor, Professor
21 Kazinets street, building 3, Minsk, 220099
Yu. G. Shanko
Belarus
Yuri G. Shanko – Dr. of Sci. (Med.), Full Professor, Corresponding Member of the National Academy of Science of Belarus
9 Filatova street, Minsk, 220026
A. V. Beletsky
Belarus
Alexander V. Beletsky – Dr. of Sci. (Med.), Full Professor, Academician of the National Academy of Science of Belarus, Honored Scientist of the Republic of Belarus, laureate of the State Prize of the Republic of Belarus
9 Frunzenskaya street, Minsk district, Borovlyany village, 223053
A. A. Shirinsky
Russian Federation
Alexander A. Shirinsky – Neurosurgeon of the Highest Category
19 Admiral Oktyabrsky street, Sevastopol, 299011
H. V. Oleshkevich
United States
Hanna V. Oleshkevich – Neurosurgeon
Richmond
References
1. Zabrodskaya Yu. M., Gaykova O. N., Gan O. V., Trofimova A. V., Gadzhiyev K. V. Patomorfology and water erectrolytic content in peritumoral brain white matter of malignant neuroectodermal tumors. Vestnik VolgGMU. 2011;3(39):42–45 (In Russ.)].
2. Ghukova T., Smeynjvic A., Pashkevich L., Bezubik C., L. Parkhach, Ahremchuk A., Chirinsky A., Khmara М. Clinicmorphologic features of the growth and recurrence of neuroepithelial tumors contaminated with herpes simplex virus. Izvestiya natsional’noy akademii nauk Belarusi. Seriya meditsinskikh nauk. 2013;(4):21–24. (In Russ.)]. Doi: 10.56618/2071–2693_2013_15_1_16. EDN: NSPSRE.
3. Nedz’ved’ M. K., Khmara M. Ye., Protas I. I., Guzov A. S. Morfologicheskiye osobennosti ostrykh i khronicheskikh gerpeticheskikh entsefalitov. Materialy I kongressa morfologov Belarusi. Minsk; 1996, рр. 65–66.
4. Preiser W., Weber B., Klos G. Unusual course of herpes simplex virus encephalitis after acyclovir therapy. Infection. 1996;(24):384–389. Doi: 10.1007/BF01716086.
5. Xinping F., Lihua T., Jin A. Expression of a Fusogenic Membrane Glycoprotein by an Oncolytic Herpes Simplex Virus Potentiates the Viral Antitumor Effect. Molecular therepi. 2003;7(6):611–623. Doi: 10.1016/s15250016(03)00092-3.
6. Arto I., Vapalahti M., Tyyne K., Hurskainen H. AdvHSVtk Gene Therapy with Intravenous Ganciclovir. Improves Survival in Human Malignant Glioma. Molecular therapy. 2004;(5):181–191. Doi: 10.1016/j.ymthe.2004.08.002.
7. Patent 18833 Resp. Belarus, MPKGO1N33/48. Sposob prognozirovania vozniknoveniia recidiva glioblastomy cherez 3–6 mesiacev / A. V. Belecky, T. V. Zhukova, S. N. Martinuk, A. L. Tanin, Y. G. Shanko, A. F. Smeianovich, A. A. Shirinskiy, S. D. Bezubik; zaiavitel. GU «RNPC travmatologii I ortopedii.». No. А20111677; opubl. 30.12.2014. Aficini bul.; Nac. Ctntr Intelectual. Ulacnacti. 2014;(6), pp. 118. Available from: http://med.by/methods [Accessed 12 February 2023].
8. Metod lechenia neyroaepitalnyh opuholey, contaminirovannuh virusom prostogo gerpesa, protivovirusnymi lekarstvennymi credstvami v combinacii c metronidazolom v rannem posleoperacionnom periode: instruccya po primeneniu No. 134-1013; ytv. M-vom zdravoohranenia Respubliki Belarus; coct. T. V. Zhukova, A. V. Belecky, S. N. Martinuk, A. F. Smeianovich, S. D. Bezubik, A. A. Shirinskiy. Sovremennye metody lechenia, i profilaktiki zabolevaniy. Available from: http://med.by/methods [Accessed 02 February 2024].
Review
For citations:
Zhukova T.V., Shanko Yu.G., Beletsky A.V., Shirinsky A.A., Oleshkevich H.V. Analysis of the clinical use of antiviral treatment in patients taking into account the morphological mechanisms of growth of glial tumors contaminated with herpes simplex virus. Russian Neurosurgical Journal named after Professor A. L. Polenov. 2024;16(2):42-49. (In Russ.) https://doi.org/10.56618/2071-2693_2024_16_2_42. EDN: MPPSJE